Fig. 2

Cell viability and expression of TNF-α, COX-2, IL-1β, and IL-6 in HMEECs upon LPS treatment. a The viability of HMEECs after treatment with 1, 5, 10, and 100 µg/mL LPS for 24 h, b The viability of HMEECs treated with 1 µg/mL LPS for 1, 3, 6, 24, and 48 h, c Image of wild-type HMEECs; d Image of HMEECs after treatment with 1 µg/mL LPS for 24 h, e COX-2 expression level in HMEECs after treatment with 1 µg/mL LPS for 24 h, f TNF-α expression level in HMEECs after treatment with 1 µg/mL LPS for 24 h, g IL-1β expression level in HMEECs after treatment with 1 µg/mL LPS for 24 h, h IL-6 expression level in HMEECs after treatment with 1 µg/mL LPS for 24 h (p-value: *** < 0.001, ** < 0.01, * < 0.05)